Nano Nuclear Energy
NNE · NASDAQ
About NNE
- Employees
- 36
- Headquarters
- New York City, New York
- Listed
- May 8, 2024
- Sector
- Industrials
- Industry
- Electrical Equipment
- Website
- nanonuclearenergy.com
NNE key statistics
- Market cap
- 698.61M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 2.04M
- Volume
- 965.80K
- Open price
- $12.66
- High today
- $13.29
- Low today
- $12.52
- 52 Week high
- $54.00
- 52 Week low
- $12.01
Nano Nuclear Energy (NNE) at a glance
Nano Nuclear Energy (NNE) last traded at $12.96, with a market cap of 698.61M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $12.52 and $13.29. The current price is 3.5% above the day's low and 2.5% below its high.
Volume so far is 965.80K shares, below the average of 2.04M shares a day.
Over the past year Nano Nuclear Energy has ranged from $12.01 to $54.00, and now sits 2% of the way up that range.
Nano Nuclear Energy met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q3 FY26 it reported -$0.19 per share against an estimate of -$0.2626.
The average analyst price target is $38.51, 197.1% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy75.0%
- Hold25.0%
- Sell0.0%
- Low
- $22.22
- Now
- $12.96
- High
- $52.50
NNE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 41.7% on average.
- Q4 FY24: reported -$0.097 per share against an estimate of -$16.16
- Q1 FY25: reported -$0.11 per share against an estimate of -$0.1818
- Q2 FY25: reported -$0.57 per share against an estimate of -$0.0909
- Q3 FY25: reported -$0.18 per share against an estimate of -$0.2054
- Q4 FY25: reported -$0.19 per share against an estimate of -$0.3106
- Q1 FY26: reported -$0.15 per share against an estimate of -$0.2475
- Q2 FY26: reported -$0.173 per share against an estimate of -$0.2651
- Q3 FY26: reported -$0.19 per share against an estimate of -$0.2626
NNE news
- Press releaseGlobe Newswire
- Press releaseNewsfile
NANO Nuclear Energy Subsidiary STS Recognized for Contributions to Two U.S. Department of Energy Award-Winning Nuclear Transportation Missions
Radnostix And NANO Nuclear Seek NRC Approval For Nuclear Fuel-Cycle Asset Transfer Of License SUB-1011
- Press releaseGlobe Newswire
Record Contract Prices Put America’s Domestic Uranium Gap Back in Focus
- Press releaseGlobe Newswire
NANO Nuclear’s KRONOS MMR™ Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
- Press releaseNewsfile
NANO Nuclear's KRONOS MMR(TM) Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
- Press releaseGlobe Newswire
NANO Nuclear Announces Participation in Several Investor Conferences
- Press releaseNewsfile
NANO Nuclear Announces Participation in Several Investor Conferences
Similar companies
Companies in the same industry as Nano Nuclear Energy
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.